Ret (phospho Tyr1015) Rabbit Polyclonal Antibody

Ret (phospho Tyr1015) Rabbit Polyclonal Antibody

Cat: APRab05364
Boyut:20μL Fiyat:$99_x000D_
Boyut:50μL Fiyat:$118_x000D_
Boyut:100μL Fiyat:$220_x000D_
Boyut:200μL Fiyat:$380_x000D_
Uygulama:WB,IHC
Reaktivite:Human,Mouse,Rat,Monkey
Konjuge:Unconjugated
İsteğe bağlı konjugeler: Biotin, FITC (ücretsiz). Diğer 26 konjugatı görün.

Gen Adı:RET
Category: ポリクローナル抗体 Tags: , , , , , , , , ,
Ret (phospho Tyr1015) Rabbit Polyclonal Antibody
Konjugasyon: Unconjugated
Rabbit polyclonal Antibody
Uygulama
IHC  ICC/IF  ELISA WB,IHC
Reaktivite
Human,Mouse,Rat,Monkey
Gen Adı
RET
Saklama
Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Özet
Ürün Adı Ret (phospho Tyr1015) Rabbit Polyclonal Antibody
Açıklama Rabbit polyclonal Antibody
Konak Rabbit
Reaktivite Human,Mouse,Rat,Monkey
Konjugasyon Unconjugated
Modifikasyon Phosphorylated
İzotip IgG
Klonalite Polyclonal
Form Liquid
Konsantrasyon Unconjugated
Saklama Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Nakliye Ice bags.
Tampon Liquid in PBS containing 50% glycerol, 0.5% protective protein and 0.02% New type preservative N.
Saflaştırma Affinity purification
Antijen Bilgisi
Gen Adı RET
Alternatif İsimler RET; CDHF12; CDHR16; PTC; RET51; Proto-oncogene tyrosine-protein kinase receptor Ret; Cadherin family member 12; Proto-oncogene c-Ret
Gen Kimliği 5979
SwissProt Kimliği P07949
İmmünojen The antiserum was produced against synthesized peptide derived from human Ret around the phosphorylation site of Tyr1015. AA range:991-1040
Uygulama
Uygulama WB,IHC
Seyreltme Oranı WB 1:500-1:2000,IHC 1:50-1:300
Moleküler Ağırlık 124kDa
Araştırma Alanı
Endocytosis;Pathways in cancer;Thyroid cancer;
Arka Plan
ret proto-oncogene(RET) Homo sapiens This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma.
   💬 WhatsApp